CMV antibody prevalence and seroincidence in plateletpheresis donors

Journal of Clinical Apheresis

Volumn 23, Issue 2, 2008, Pages 63-65

  Boeke, Caroline E ^a   Pauly, Megan E ^a   Hatch Stock, Holly ^a   Jackson, J Brooks ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Cytomegalovirus; Plateletpheresis donors; Prevalence; Seroincidence

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; FEMALE; HUMAN; MALE; MEDICAL RECORD; SEROCONVERSION; SEROLOGY; SEX DIFFERENCE; THROMBOCYTOPHERESIS;

ADULT; ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD PLATELETS; CYTOMEGALOVIRUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLASMAPHERESIS; PREVALENCE;

EID: 43249096709     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20157     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. About CMV. Atlanta: CDC, 2006. Available at: http://www.cdc.gov/cmv/facts.htm (Accessed July 27, 2007).
2. Adler SP. Transfusion-associated cytomegalovirus infections. Rev Infect Dis 1983;5:977-993.
3. Roback JD. CMV and blood transfusions. Rev Med Virol 2002; 12:211-219.
4. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990;12(Suppl 7):S754-S766.
5. Preiksaitis JK. Indications for the use of cytomegalovirus-seronegative blood products. Transfus Med Rev 1991;5:1-17.
6. Galea G, Urbaniak SJ. Cytomegalovirus studies on blood donors in north-east Scotland and a review of UK data. Vox Sang 1993;64:24-30.
7. Hecker M, Qiu D, Marquardt K, Bein G, Hacksteid H. Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang 2004;86:41-44.
8. Sheevani, Jindal N, Aggarwal A. A pilot seroepidemiological study of cytomegalovirus infection in women of child bearing age. Indian J Med Microbiol 2005;23:34-36.
9. Staras SAS, Dollard SC, Radford KW, Flanders WD, Pass RG, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. CID 2006;43:1143-1151.
10. Bayer WL, Tegtmeier GE. The blood donor: detection and magnitude of cytomegalovirus carrier states and the prevalence of cytomegalovirus antibody. Yale J Biol Med 1976;49:5-12.
11. Jack I, McAuliffe KC. Sero-epidemiological study of cytomegalovirus infections in Melbourne children and some adults. Med J Aust 1968;1:206-209.
12. Kothari A, Ramachandran VG, Gupta P, Singh B, Talwar V. Seroprevalence of cytomegalovirus among voluntary blood donors in Dehli, India. J Health Popul Nutr 2002;20:348-351.
13. Krech U. Complement fixing antibodies against CMV in different parts of the world. Bull WHO 1973;49:103-106.
14. White NH, Yow MD, Demmler GJ, Norton HJ, Hoyle J, Pinckard K, Mishaw C, Pokorny S. Prevalence of cytomegalovirus antibody in subjects between the ages of 6 and 22 years. JID 1989;159:1013-1017.
15. Dworsky ME, Welch K, Cassady G, Stagno S. Occupational risk for primary cytomegalovirus infection among pediatric health-care workers. N Engl J Med 1983;309:950-953.